)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Divi’s Laboratories (DIVISLAB) investor relations material
Divi’s Laboratories Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary7 Nov, 2025
Executive summary
Delivered strong Q2 FY2026 results with 17% YoY revenue growth and robust profit expansion, driven by custom synthesis and stable generics volumes despite pricing pressure.
Maintained operational stability amid global trade shifts, leveraging backward integration and diversified supply chain.
Continued investments in capacity, technology, and R&D, with three major CapEx programs underway.
Peptide business gained momentum with a new Center of Excellence and multiple projects in development.
Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY26, with strong year-over-year growth in revenue and profit.
Financial highlights
Q2 FY2026 consolidated income: INR 2,860 crore, up 17% YoY; profit after tax: INR 689 crore (vs. INR 510 crore YoY); forex gain of INR 63 crore in Q2.
H1 FY2026 consolidated income: INR 5,389 crore, up 16% YoY; profit after tax: INR 1,234 crore (vs. INR 940 crore YoY).
Standalone Q2 FY26 total income: INR 2,806 crore; PAT: INR 696 crore.
Material consumption at 39.5% of sales revenue for the quarter; exports accounted for 90% of sales, with Europe and US contributing 74%.
Product mix: 44% generics, 56% custom synthesis in Q2; nutraceuticals revenue at INR 242 crore for the quarter.
Outlook and guidance
Expectation of continued pricing pressure in generics for the next few quarters, with potential stabilization thereafter.
Custom synthesis pipeline robust, with several projects expected to move to commercial manufacturing in 1–2 years, subject to regulatory approvals.
CapEx for FY2026 to exceed previous INR 2,000 crore guidance, driven by new projects and capacity expansion across all units.
Management commentary highlights continued focus on operational efficiency and growth in the nutraceutical segment.
Peptide manufacturing: future investment scale
Gross margin outlook given product mix shift
Unit 3: GMP qualification for API production
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Divi’s Laboratories earnings date
Q3 25/262 Feb, 2026
Next Divi’s Laboratories earnings date
Q3 25/262 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients for global pharmaceutical companies. The company specializes in custom synthesis and contract manufacturing for generic and branded drugs. Divi’s Laboratories serves customers in regulated markets including the United States and Europe. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage